Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (191-200 of 418) with videos related to

Pageof 42
Sort By:
Cancers|June 2, 2021
Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-MutationsPaolo Bironzo, Maria Lucia Reale, Tessa Sperone, et al.
Tumori|February 25, 2026
Patient-reported financial toxicity within Italian public healthcare system: A cross-sectional analysis in patients with cancerAnna Amela Valsecchi, Pamela Festa, Maria Laura Malgarini, et al.
Anticancer Research|November 1, 2016
Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity ReactionsMarco Tampellini, Simone Benedetto, Elena Rubatto, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Bridging Gaps in Cancer Pain Care: Barriers, Solutions, and a Path Forward for Integrated ManagementMarta Gentili, Francesco Cellini, Leonardo Consoletti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancerMassimo Di Maio, Paolo Chiodini, Vassilis Georgoulias, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2014
Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international databaseMatan J Cohen, Izhar Levy, Orly Barak, et al.
Critical Reviews in Oncology/Hematology|March 8, 2022
Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic reviewAlberto Servetto, Fabio Salomone, Fabrizio Di Costanzo, et al.
Clinics and Research in Hepatology and Gastroenterology|March 31, 2021
Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH surveyDebora Basile, Claire Gallois, Fabio Puglisi, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 25, 2006
Significance of erb-B2 immunoreactivity in cervical cancerDaniela Califano, Simona Losito, Carmela Pisano, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2014
Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancerNicola Normanno, Antonio Rossi, Alessandro Morabito, et al.
Pageof 42

Showing results (191-200 of 418) with videos related to

Sort By:
Pageof 42
Cancers|June 2, 2021
Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-MutationsPaolo Bironzo, Maria Lucia Reale, Tessa Sperone, et al.
Tumori|February 25, 2026
Patient-reported financial toxicity within Italian public healthcare system: A cross-sectional analysis in patients with cancerAnna Amela Valsecchi, Pamela Festa, Maria Laura Malgarini, et al.
Anticancer Research|November 1, 2016
Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity ReactionsMarco Tampellini, Simone Benedetto, Elena Rubatto, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Bridging Gaps in Cancer Pain Care: Barriers, Solutions, and a Path Forward for Integrated ManagementMarta Gentili, Francesco Cellini, Leonardo Consoletti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancerMassimo Di Maio, Paolo Chiodini, Vassilis Georgoulias, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2014
Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international databaseMatan J Cohen, Izhar Levy, Orly Barak, et al.
Critical Reviews in Oncology/Hematology|March 8, 2022
Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic reviewAlberto Servetto, Fabio Salomone, Fabrizio Di Costanzo, et al.
Clinics and Research in Hepatology and Gastroenterology|March 31, 2021
Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH surveyDebora Basile, Claire Gallois, Fabio Puglisi, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 25, 2006
Significance of erb-B2 immunoreactivity in cervical cancerDaniela Califano, Simona Losito, Carmela Pisano, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2014
Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancerNicola Normanno, Antonio Rossi, Alessandro Morabito, et al.
Pageof 42